vs

Side-by-side financial comparison of MP Materials Corp. (MP) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $52.7M, roughly 1.4× MP Materials Corp.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -13.6%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-109.3M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 4.0%).

MP Materials Corp. is a U.S.-based producer of rare earth materials. The company owns and operates the Mountain Pass mine in California, the only active rare earth mining and processing facility in the Western Hemisphere, producing essential materials for electric vehicles, wind turbines, and defense applications.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

MP vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.4× larger
PBYI
$75.5M
$52.7M
MP
Growing faster (revenue YoY)
PBYI
PBYI
+41.3% gap
PBYI
27.7%
-13.6%
MP
More free cash flow
PBYI
PBYI
$123.6M more FCF
PBYI
$14.4M
$-109.3M
MP
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
4.0%
MP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MP
MP
PBYI
PBYI
Revenue
$52.7M
$75.5M
Net Profit
$9.4M
Gross Margin
69.3%
Operating Margin
-7.0%
22.7%
Net Margin
17.9%
Revenue YoY
-13.6%
27.7%
Net Profit YoY
142.2%
EPS (diluted)
$0.07
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MP
MP
PBYI
PBYI
Q4 25
$52.7M
$75.5M
Q3 25
$53.6M
$54.5M
Q2 25
$57.4M
$52.4M
Q1 25
$60.8M
$46.0M
Q4 24
$61.0M
$59.1M
Q3 24
$62.9M
$80.5M
Q2 24
$31.3M
$47.1M
Q1 24
$48.7M
$43.8M
Net Profit
MP
MP
PBYI
PBYI
Q4 25
$9.4M
Q3 25
$-41.8M
$8.8M
Q2 25
$-30.9M
$5.9M
Q1 25
$-22.6M
$3.0M
Q4 24
$-22.3M
Q3 24
$-25.5M
$20.3M
Q2 24
$-34.1M
$-4.5M
Q1 24
$16.5M
$-4.8M
Gross Margin
MP
MP
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
MP
MP
PBYI
PBYI
Q4 25
-7.0%
22.7%
Q3 25
-125.2%
17.6%
Q2 25
-76.5%
12.7%
Q1 25
-57.2%
8.7%
Q4 24
-72.1%
22.6%
Q3 24
-62.8%
27.4%
Q2 24
-171.1%
-4.6%
Q1 24
-66.6%
-5.3%
Net Margin
MP
MP
PBYI
PBYI
Q4 25
17.9%
Q3 25
-78.0%
16.2%
Q2 25
-53.8%
11.2%
Q1 25
-37.2%
6.5%
Q4 24
-36.6%
Q3 24
-40.5%
25.2%
Q2 24
-108.9%
-9.6%
Q1 24
33.9%
-11.0%
EPS (diluted)
MP
MP
PBYI
PBYI
Q4 25
$0.07
$0.26
Q3 25
$-0.24
$0.17
Q2 25
$-0.19
$0.12
Q1 25
$-0.14
$0.06
Q4 24
$-0.12
$0.40
Q3 24
$-0.16
$0.41
Q2 24
$-0.21
$-0.09
Q1 24
$-0.08
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MP
MP
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$1.2B
$97.5M
Total DebtLower is stronger
$998.7M
$22.7M
Stockholders' EquityBook value
$2.0B
$130.3M
Total Assets
$3.9B
$216.3M
Debt / EquityLower = less leverage
0.50×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MP
MP
PBYI
PBYI
Q4 25
$1.2B
$97.5M
Q3 25
$1.1B
$94.4M
Q2 25
$261.5M
$96.0M
Q1 25
$198.3M
$93.2M
Q4 24
$282.4M
$101.0M
Q3 24
$284.4M
$96.7M
Q2 24
$295.6M
$96.8M
Q1 24
$296.5M
$107.2M
Total Debt
MP
MP
PBYI
PBYI
Q4 25
$998.7M
$22.7M
Q3 25
$997.3M
$34.0M
Q2 25
$910.8M
$45.3M
Q1 25
$909.8M
$56.7M
Q4 24
$908.7M
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
MP
MP
PBYI
PBYI
Q4 25
$2.0B
$130.3M
Q3 25
$2.0B
$115.3M
Q2 25
$1.0B
$104.7M
Q1 25
$1.0B
$97.1M
Q4 24
$1.1B
$92.1M
Q3 24
$1.1B
$71.1M
Q2 24
$1.1B
$48.5M
Q1 24
$1.1B
$51.0M
Total Assets
MP
MP
PBYI
PBYI
Q4 25
$3.9B
$216.3M
Q3 25
$3.8B
$202.9M
Q2 25
$2.3B
$194.9M
Q1 25
$2.4B
$196.2M
Q4 24
$2.3B
$213.3M
Q3 24
$2.3B
$220.7M
Q2 24
$2.4B
$205.0M
Q1 24
$2.4B
$214.1M
Debt / Equity
MP
MP
PBYI
PBYI
Q4 25
0.50×
0.17×
Q3 25
0.51×
0.30×
Q2 25
0.90×
0.43×
Q1 25
0.88×
0.58×
Q4 24
0.86×
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MP
MP
PBYI
PBYI
Operating Cash FlowLast quarter
$-46.9M
$14.4M
Free Cash FlowOCF − Capex
$-109.3M
$14.4M
FCF MarginFCF / Revenue
-207.4%
19.1%
Capex IntensityCapex / Revenue
118.5%
0.0%
Cash ConversionOCF / Net Profit
-4.97×
TTM Free Cash FlowTrailing 4 quarters
$-328.1M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MP
MP
PBYI
PBYI
Q4 25
$-46.9M
$14.4M
Q3 25
$-42.0M
$9.7M
Q2 25
$-3.7M
$14.1M
Q1 25
$-63.2M
$3.6M
Q4 24
$30.5M
$15.6M
Q3 24
$-6.8M
$11.0M
Q2 24
$30.8M
$1.0M
Q1 24
$-41.1M
$11.2M
Free Cash Flow
MP
MP
PBYI
PBYI
Q4 25
$-109.3M
$14.4M
Q3 25
$-92.5M
$9.7M
Q2 25
$-32.7M
$14.1M
Q1 25
$-93.7M
$3.6M
Q4 24
$-11.2M
$15.6M
Q3 24
$-53.3M
$11.0M
Q2 24
$-15.6M
$1.0M
Q1 24
$-93.0M
FCF Margin
MP
MP
PBYI
PBYI
Q4 25
-207.4%
19.1%
Q3 25
-172.8%
17.7%
Q2 25
-56.9%
26.8%
Q1 25
-154.0%
7.7%
Q4 24
-18.3%
26.4%
Q3 24
-84.7%
13.7%
Q2 24
-50.1%
2.1%
Q1 24
-191.0%
Capex Intensity
MP
MP
PBYI
PBYI
Q4 25
118.5%
0.0%
Q3 25
94.3%
0.0%
Q2 25
50.5%
0.0%
Q1 25
50.1%
0.1%
Q4 24
68.3%
0.0%
Q3 24
73.8%
0.0%
Q2 24
148.7%
0.0%
Q1 24
106.5%
0.0%
Cash Conversion
MP
MP
PBYI
PBYI
Q4 25
-4.97×
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24
-2.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MP
MP

Materials Segment$35.6M68%
Other$17.1M32%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons